ORAGENICS, INC. (OGEN) Operating income 2016–2025
ORAGENICS, INC. (OGEN) annual operating income history from SEC filings — each fiscal year as reported.
-$9.4MFY2025 · since FY2016: -$8.5M → -$9.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$9.4M | +11.3% |
| FY2024 | -$10.6M | +49.5% |
| FY2023 | -$20.9M | -45.0% |
| FY2022 | -$14.4M | +8.6% |
| FY2021 | -$15.8M | +40.8% |
| FY2020 | -$26.6M | -67.8% |
| FY2019 | -$15.9M | -58.9% |
| FY2018 | -$10.0M | -48.8% |
| FY2017 | -$6.7M | +21.4% |
| FY2016 | -$8.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More OGEN financial trends
OGEN RevenueOGEN Net incomeOGEN Net marginOGEN Gross profitOGEN Gross marginOGEN Operating marginOGEN Operating cash flowOGEN Free cash flowOGEN Capital expendituresOGEN Return on equityOGEN Stock buybacksOGEN Dividends paidOGEN Total assetsOGEN Total liabilitiesOGEN Shareholders’ equityOGEN overview →